Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Sci Data ; 9(1): 610, 2022 10 08.
Artigo em Inglês | MEDLINE | ID: mdl-36209289

RESUMO

Viruses are genetically and structurally diverse, and outnumber cells by orders of magnitude. They can cause acute and chronic infections, suppress, or exacerbate immunity, or dysregulate survival and growth of cells. To identify chemical agents with pro- or antiviral effects we conducted arrayed high-content image-based multi-cycle infection screens of 1,280 mainly FDA-approved compounds with three human viruses, rhinovirus (RV), influenza A virus (IAV), and herpes simplex virus (HSV) differing in genome organization, composition, presence of an envelope, and tropism. Based on Z'-factors assessing screening quality and Z-scores ranking individual compounds, we identified potent inhibitors and enhancers of infection: the RNA mutagen 5-Azacytidine against RV-A16; the broad-spectrum antimycotic drug Clotrimazole inhibiting IAV-WSN; the chemotherapeutic agent Raltitrexed blocking HSV-1; and Clobetasol enhancing HSV-1. Remarkably, the topical antiseptic compound Aminacrine, which is clinically used against bacterial and fungal agents, inhibited all three viruses. Our data underscore the versatility and potency of image-based, full cycle virus propagation assays in cell-based screenings for antiviral agents.


Assuntos
Anti-Infecciosos Locais , Herpes Simples , Vírus da Influenza A , Aminacrina/uso terapêutico , Anti-Infecciosos Locais/uso terapêutico , Antivirais/farmacologia , Azacitidina/uso terapêutico , Clobetasol/uso terapêutico , Clotrimazol/uso terapêutico , Herpes Simples/tratamento farmacológico , Humanos , Mutagênicos/uso terapêutico , Rhinovirus
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA